Your Safety is Our Priority

You Protect Patients, We Protect You

EQUASHIELD® is dedicated to protecting healthcare workers from hazardous drug exposure by developing automated compounding solutions and closed system transfer devices.

85%

Oncology Healthcare Workers
85% tested positive for biomarkers of exposure to hazardous drugs in urine analysis 1

94%

Oncology Healthcare Workers
had a 94% increased risk of spontaneous abortion 2

350%

Oncology Healthcare Workers had a 350% increased risk of spontaneous abortion among women who previously had a miscarriage or abortion 2

400%

Physicians who routinely handle antineoplastic drugs had a 400% increase in risk for developing leukemia, lymphatic, and hematopoietic cancers 3

20%

Oncology Healthcare Workers handling anticancer drugs had a 20% increase in Chromosomal abnormality 4

100%

Oncology Pharmacists had a 100% increase in mortality from myeloid leukemia 4

Even Minimal Exposure to HD is Dangerous

CMRs are classified into categories of Carcinogens, Mutagens and Reprotoxic hazards, each with various risks.5

Long Term

white cancer icon

Cancer

genetic and developmental issues

Genetic and Developmental Issues

white cancer icon

Cancer

reprotoxic issues white icon

Reprotoxic
Issues

damage to internal organs white icon

Damage to Internal Organs

white cancer icon

Cancer

Acute

hair loss white icon

Hair Loss

infection white icon

Infection

taste disturbances white icon

Taste
Disturbances

respiratory disease white icon

Respiratory
Disease

reproductive issues white icon

Reproductive
Issues

headaches white icon

Headaches

Long Term

white cancer icon

Cancer

genetic and developmental issues

Genetic and Developmental Issues

reprotoxic issues white icon

Reprotoxic
Issues

damage to internal organs white icon

Damage to Internal Organs

Acute

hair loss white icon

Hair Loss

infection white icon

Infection

taste disturbances white icon

Taste Disturbances

respiratory disease white icon

Respiratory Disease

reproductive issues white icon

Reproductive Issues

headaches white icon

Headaches

You Deserve to be Safer

 At EQUASHIELD®, we prioritize safety and operational excellence in the healthcare field. Our solutions are engineered to prevent errors, enhance healthcare provider and patient safety, and streamline workflows—all with cutting-edge technology and user centered design.

You Deserve to be Safer

At EQUASHIELD®, we prioritize safety and operational excellence in the healthcare field. Our solutions are engineered to prevent errors, enhance healthcare provider and patient safety, and streamline workflows—all with cutting-edge technology and user centered design.

EQUASHIELD® Leads the U.S. CSTD Market

For the seventh consecutive year, we lead the industry as the most used CSTD in pharmacy in the U.S.6

Safer Design

Every element of EQUASHIELD products are designed to be safer

Simpler Design

Simplifying safety with ergonomic and easy to use components

Safety in Automation

Eliminates human error, eliminate exposure risks, reduce, improved patient safety

Not All CSTD are Created Equal

CSTD design affects its ability to be safe and effective

Luer vs. Membrane

Membrane based systems are typically better at leakage prevention than Luer based CSTDs. Testing data consistently highlights EQUASHIELD® as a top performer among membrane-based solutions, effectively preventing microbial ingress.7

Filter vs. Mechanical

Filter based technologies are not mechanically closed, therefore they are not air tight. Mechanical based technologies are designed to ensure an airtight and leak-proof seal through robust physical barriers.

Open Back vs. Closed Back

A closed-back design provides significant safety benefits, including effective containment of vapors and prevention of their release.8 It also safeguards the syringe plunger and barrel from contamination. EQUASHIELD® is the only solution on the market featuring a closed-back design.

Engineered for Maximal Safety

EQUASHIELD® Syringe Units maintain a closed pressure equalization that prevents the escape of vapors and aerosols during compounding and administration. A unique dual-needle, air-to-liquid exchange system, combined with a closed-back sterile air chamber behind the syringe, ensures that pressure is equalized  throughout the hazardous drug handling process.

EQUASHIELD®’s Vial Adaptor firmly snaps onto a standard vial with a unique mechanism that prevents angled or non-centered spiking. The vial adaptor provides a safe and contamination-free vial access port for the Syringe Unit. The vial adaptor’s elastomeric membrane serves as a microbial barrier preventing microbial ingress, while remaining drug residue-free for up to 10 repeated connections in 7 days.

EQUASHIELD’s Spike Adaptors are designed to seamlessly connect standard IV bags to tubing sets, ensuring the safe transfer of hazardous drugs. Engineered with precision, they empower healthcare professionals to compound and administer medications with confidence and ease.

EQUASHIELD® Female Connectors convert standard luer lock ports into a leak-free closed system, ensuring safe and residue-free handling of hazardous drugs. Designed for secure connections and disconnections, they prioritize safety and reliability.

EQUASHIELD® Luer Lock Adaptors ensure a secure connection to patient lines, enabling safe injections with the EQUASHIELD® Syringe Unit or controlled infusions using a female connector. Compatible with any standard luer lock access port, these adaptors are meticulously designed to provide safe, reliable, and efficient administration of hazardous drugs.

Engineered for Maximal Safety

EQUASHIELD® Syringe Units maintain a closed pressure equalization that prevents the escape of vapors and aerosols during compounding and administration. A unique dual-needle, air-to-liquid exchange system, combined with a closed-back sterile air chamber behind the syringe, ensures that pressure is equalized  throughout the hazardous drug handling process.

EQUASHIELD®’s Vial Adaptor firmly snaps onto a standard vial with a unique mechanism that prevents angled or non-centered spiking. The vial adaptor provides a safe and contamination-free vial access port for the Syringe Unit. The vial adaptor’s elastomeric membrane serves as a microbial barrier preventing microbial ingress, while remaining drug residue-free for up to 10 repeated connections in 7 days.

EQUASHIELD’s Spike Adaptors are designed to seamlessly connect standard IV bags to tubing sets, ensuring the safe transfer of hazardous drugs. Engineered with precision, they empower healthcare professionals to compound and administer medications with confidence and ease.

EQUASHIELD® Female Connectors convert standard luer lock ports into a leak-free closed system, ensuring safe and residue-free handling of hazardous drugs. Designed for secure connections and disconnections, they prioritize safety and reliability.

EQUASHIELD® Luer Lock Adaptors ensure a secure connection to patient lines, enabling safe injections with the EQUASHIELD® Syringe Unit or controlled infusions using a female connector. Compatible with any standard luer lock access port, these adaptors are meticulously designed to provide safe, reliable, and efficient administration of hazardous drugs.

What Happens in EQUASHIELD®
Stays in EQUASHIELD®

Our patented closed back design is leakproof and airtight

EQUASHIELD® covers more routes of exposure than alternative systems. Backed by 25 peer-reviewed and independent clinical studies, our solution ensures leakproof performance, microbial protection, vapor containment, prevention of plunger rod and surface contamination. Choose EQUASHIELD® for safety you can trust.

Clinically Backed to be Safer

Safety Shouldn’t be Complicated

EQUASHIELD® CSTD design makes premium safety simple

/01

Ergonomic design

Ergonomically designed with push on connections vs twist connections. This minimizes repetitive motion injuries (RSIs), reducing the risk of joint pain and carpal tunnel syndrome.

/02

Fail proof connections with red to red markings

Intuitive red markings serve as an alignment indicator, ensuring accurate and secure connections every time.

/03

Pre-bonded components

Pre-welded syringe units and connectors save time and effort. The connector is securely bonded to the syringe and locking connectors, housing shielded needles to prevent accidental needle sticks and disconnects.

/04

No external mechanisms required

EQUASHIELD®’s innovative design streamlines the compounding and administration process by eliminating the need for balloons or external mechanisms required by other systems.

/05

Fastest CSTD to compound and administer

EQUASHIELD® is faster and more efficient to use- requiring the fewest steps to compound, and the lowest average time for administering- the fewest of tested CSTD competitors. 9,10

/06

Full volume use

FDA cleared to use the full volume of the syringe unit. Benefit from cost savings, reduced strain, time savings, and waste reduction.11

The Future of Safety in Automation

Mundus Mini HD is safer, faster, and effortlessly integrates with your team. By automating manual compounding processes, it significantly reduces the risk of human error. Let Mundus Mini HD handle the repetitive tasks, so your team can focus on what matters most.

Protecting Healthcare Workers

/ Eliminates HD exposure risks

Seamlessly integrating CSTD throughout the lifecycle eliminates risk of exposure to hazardous drugs.

/ Protects against RSIs

By automating repetitive tasks and reducing the need for physical labor, the risk of repetitive strain injuries can be avoided.

/ Ensures process traceability

Automating documentation eliminates manual data entry, ensures seamless digital traceability, and provides a clear audit trail.

Protecting Patients

/ Eliminate human errors

A recent ISMP survey records an 9% average error rate with manual compounding.12

/ Ensure accurate drug compounding

Prevent mistakes such as incorrect drugs, dosages, or compounding techniques with advanced image processing technology.

/ Ensure exceptional precision in administration

The Mundus Mini HD offers an accuracy rate of 1%, outperforming other automation solutions with a 5% margin of error and manual compounding at 4%-5%.

What Our Customers Say About Us

Our Mission is to Ensure Your Safety

The EQUASHIELD® Clinical Team consists of certified pharmacy technicians and registered nurses. Our mission is to protect healthcare teams from exposure to hazardous drugs. With decades of clinical experience and advanced certifications in sterile compounding and oncology nursing, we understand your needs and speak your language in order to ensure seamless integration of our CSTD and automated compounding solutions.

References:

  1. Wick C, Slawson MH, Jorgenson JA, Tyler LS, et al. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60:2314–2320.
  2. Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational exposures among nurses and risk of spontaneous abortions. Am J Obstet Gynecol. 2012;206:e1–e8.
  3. M.A. McDiarmid, M.S. Oliver, T.S. Roth, B. Rogers, C.P. Escalante, Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs, J. Occup. Environ. Med. 52 (2010) 1028–1034.
  4. S.A. Petralia, M. Dosemeci, E.E. Adams, S.H. Zahm, Cancer mortality among women employed in health care occupations in 24 U.S. states, 1984–1993, Am. J. Ind. Med. 36 (1999) 159–165
  5. National Institute for Occupational Safety and Health (NIOSH). (2004). Preventing occupational exposures to antineoplastic and other hazardous drugs in healthcare settings (DHHS (NIOSH) Publication Number 2004−165). Retrieved from https://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf
  6. Pharmacy Purchasing and Products. “State of Pharmacy Compounding,” Volume 22, Number 4, page 60, April 2025 https://www.pppmag.com/digitalmag/Main.php?MagNo=403&PageNo=1#page/62.
  7. Connector Integrity Testing to Assess the Efficacy of Multiple Closed System Transfer Devices – University of North Carolina; Shawn O. Streeter¹, Charlotte M. Forshay¹, Stephanie A. Salch¹, Stephen F. Eckel, PharmD, MHA, BCPS¹,², North Carolina, United States, 2016. https://www.equashield.com/clinical-studies/connector-integrity-testing-to-assess-the-efficacy-of-multiple-closed-system-transfer-devices/
  8. Forshay, M., Streeter, S. O., Salch, S. A., & Eckel, S. F. (2018). Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs. University of North Carolina, Charlotte.  https://www.equashield.com/clinical-studies/application-of-the-2015-proposed-niosh-vapor-containment-performance-protocol-for-closed-system-transfer-devices-used-during-pharmacy-compounding-and-administration-of-hazardous-drugs/
  9. Berdi, F. (2015). Comparing The Efficiency of Closed System Transfer Devices for Compounding Pharmacy Practice & Products. (https://www.equashield.com/clinical-studies/comparing-the-efficiency-of-closed-system-transfer-devices-for-compounding/)
  10. Kicenuik, K., Northrup, N., Dawson, A., Locke, J., Villamil, J. A., Chretin, J., Sfiligoi, G., Clifford, C., Rosenberg, M., Hamilton, T., Regan, R., ParsonsDoherty, M., Mallett, C., Philibert, J., Impellizeri, J., & Hofmeister, E. (2015). Treatment Time, Ease of Use, and Cost Associated With the Use of Equashield™, PhaSeal®, or No Closed System Transfer Device for Administration of Cancer Chemotherapy to a Dog Model. University of Georgia, USA. Retrieved from https://www.equashield.com/clinical-studies/equashield-phaseal-no-cstd-for-administration-of-cancer-chemotherapy-to-dog-model/
  11. FDA Clearance of EQUASHIELD® Syringe Unit for Full Volume Use, EQUASHIELD, October 2023, https://www.equashield.com/articles/fda-clearance-of-equashield-syringe-unit-for-full-volume-use/
  12. Institute for Safe Medical Practices. Proceedings from the ISMP Sterile Preparation Compounding Safety Summit for SAFE Preparation of Sterile Compounds. 2013:  http://bit.ly/2wVNSZX